Results
1
-
10
of
93
<
1
2
3
...
9
10
>
Lopes JF; Hubatsch DA; Amaris P.
Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
,
BMC ophthalmology
[DOI: 10.1186/s12886-015-0151-7]
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY.
24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
,
Advances in therapy
[DOI: 10.1007/s12325-014-0125-9]
Crichton AC; Vold S; Williams JM; Hollander DA.
Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
,
Advances in therapy
[DOI: 10.1007/s12325-013-0014-7]
Whitson JT; Petroll WM.
Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
,
Advances in therapy
[DOI: 10.1007/s12325-012-0057-1]
Kawaguchi I; Higashide T; Ohkubo S; Kawaguchi C; Sugiyama K.
Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.
,
Japanese journal of ophthalmology
[DOI: 10.1007/s10384-012-0155-2]
Sawada A; Yamamoto T; Takatsuka N.
Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.
,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
[DOI: 10.1007/s00417-011-1762-1]
Fain JM; Kotak S; Mardekian J; Bacharach J; Edward DP; Rauchman S; Brevetti T; Fox JL; Lovelace C.
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-11-13]
Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C.
Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
,
Advances in therapy
[DOI: 10.1007/s12325-011-0003-7]
Ryan G Jr; Fain JM; Lovelace C; Gelotte KM.
Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-11-8]
Ammar DA; Noecker RJ; Kahook MY.
Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
,
Advances in therapy
[DOI: 10.1007/s12325-010-0070-1]
<
1
2
3
...
9
10
>